LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹93 Cr | ₹73 Cr | ₹69 Cr | ₹62 Cr | ₹51 Cr |
What is the latest Consolidated Net Profit of LINCOLN PHARMACEUTICALS ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹93 Cr |
Mar2023 | ₹73 Cr |
Mar2022 | ₹69 Cr |
Mar2021 | ₹62 Cr |
Mar2020 | ₹51 Cr |
How is Consolidated Net Profit of LINCOLN PHARMACEUTICALS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹93 Cr | 27.99 | |
Mar2023 | ₹73 Cr | 5.11 | |
Mar2022 | ₹69 Cr | 11.41 | |
Mar2021 | ₹62 Cr | 21.02 | |
Mar2020 | ₹51 Cr | - |
Compare Consolidated Net Profit of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,122.7 Cr | -2.7% | 2% | -7.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹399,249.0 Cr | -1.3% | -3.3% | 8.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,940.0 Cr | -1.5% | 0.8% | 42.3% | Stock Analytics | |
CIPLA | ₹121,197.0 Cr | -1.7% | 2.3% | -5.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,618.0 Cr | -1.6% | 8.4% | 10.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,250.0 Cr | -3.3% | -1.4% | 9.8% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -2.7% |
2% |
-7.3% |
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses